{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:16:14Z","timestamp":1788434174288,"version":"build-2803163510"},"reference-count":40,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22425505"],"award-info":[{"award-number":["22425505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA0909400"],"award-info":[{"award-number":["2021YFA0909400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>Oral bacteriotherapy has given rise to an unprecedented potential in treating a variety of diseases, especially gastrointestinal tract-associated immune and metabolic disorders, through reversing microbial imbalance-induced physiological dysfunctions. However, living therapeutic bacteria are often plagued by unsatisfactory treatment outcomes due to their impaired oral viability, unpredictable intestinal distribution, and undesired in vivo colonization. Controlled delivery of therapeutic bacteria via customized vehicles is able to overcome these difficulties by protecting a bacteria from environmental insults, selectively releasing in the intestine, and\/or increasing targeted accumulation at the lesion site. Recently, remarkable efforts have been made on cell surface modification to improve the in vivo delivery of therapeutic bacteria based on specific physiological environments and\/or pathological features. Among these purposive modification strategies, the formation of a stimuli-responsive nanocoating represents a versatile platform to introduce bacteria with extra functions, such as enhanced resistance, site-specific exposure, and physiological signal-triggered in situ activation in the gastrointestinal tract, offering a promising approach for precisely delivering therapeutic bacteria for advanced oral bacteriotherapy.<\/jats:p>\n                  <jats:p>In this Account, we summarize the recent advances from our group in manipulating bacterial behaviors through the construction of gastrointestinal stimuli-responsive nanocoatings, with the aim to enable controlled oral delivery of living therapeutic bacteria. First, we report the use of available reactive moieties on the bacterial surface to form diverse stimuli-responsive nanocoatings without affecting bacterial viability. By virtue of abundant intermolecular interactions, such as electrostatic attraction, hydrophobic adsorption, \u03c0\u2013\u03c0 stacking, coordination bonding, or heterogeneous nucleation mineralization, nanocoatings consisting of functional small molecules, polymers, and\/or nanoparticles can be formed on the bacterial surface. We describe how these nanocoatings can intelligently respond to specific gastrointestinal stimuli, thereby enabling the controlled oral delivery of modified bacteria. For instance, the introduction of a gastric acid-responsive nanocoating can neutralize acidic insult to enhance bacterial tolerance, ensuring the passage of intact bacteria through the stomach. Additionally, an enteric nanocoating can be triggered to dissolve in response to pH fluctuation, consequently rendering a selective release of therapeutic bacteria in the intestine. Moreover, equipping bacteria with a pathological signal-sensitive nanocoating enables the controllable exposure of therapeutic bacteria at the lesion site, achieving targeted delivery to the lesion site. Then, we show the advantages of stimuli-responsive nanocoating-enabled controlled oral delivery of therapeutic bacteria for disease intervention. Specifically, we highlight the applications involving the treatment of intestinal infections, the alleviation of chemically induced ulcerative mucositis, the synergistic treatment of pathogen-induced colitis, and the prevention of gut microbiota disorder-caused atherosclerosis. Lastly, we discuss the prospects and challenges of using stimuli-responsive nanocoatings to manipulate the functions of therapeutic bacteria for controlled oral delivery and corresponding disease management, particularly the translational potential from laboratory research to clinical implementations. We anticipate that these stimuli-responsive nanocoating-based oral delivery systems proposed in this Account, as well as their tunable interplays with the gastrointestinal environments, will advance the development of next-generation living therapeutics and provide innovative strategies for disease intervention.<\/jats:p>","DOI":"10.1021\/acs.accounts.6c00272","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:02:07Z","timestamp":1786341727000},"page":"2761-2772","source":"Crossref","is-referenced-by-count":0,"title":["Stimuli-Responsive\nNanocoatings Enable Controlled\nOral Delivery of Therapeutic Bacteria"],"prefix":"10.1021","volume":"59","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200127"]},{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200240"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8230-4021","authenticated-orcid":true,"given":"Xiao","family":"Kuang","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200127"]},{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200125"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-2033","authenticated-orcid":true,"given":"Jinyao","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University , , ,","place":["Shanghai, China, 200127"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"11","key":"2026090306314739600_cit1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade0997","article-title":"Biointerface\nmineralization generates ultraresistant gut microbes as oral biotherapeutics","volume":"9","author":"Geng","year":"2023","journal-title":"Sci. Adv."},{"issue":"34","key":"2026090306314739600_cit2","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002406","article-title":"On-demand bacterial\nreactivation by restraining within a triggerable nanocoating","volume":"32","author":"Feng","year":"2020","journal-title":"Adv. Mater."},{"issue":"49","key":"2026090306314739600_cit3","doi-asserted-by":"publisher","first-page":"26932","DOI":"10.1021\/jacs.3c10015","article-title":"Triggerable prodrug nanocoating enables on-demand activation of microbial\nand small-molecular therapeutics for combination treatment","volume":"145","author":"Kuang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"41","key":"2026090306314739600_cit4","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady9183","article-title":"Generating theranostic bacteria by\ndepositing a protective visual therapeutic nanocoating via in situ\nsequential mineralization","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"issue":"9","key":"2026090306314739600_cit5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human\nmetabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"2026090306314739600_cit6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/s44320-024-00067-0","article-title":"Bacterial live therapeutics for human\ndiseases","volume":"20","author":"Frutos-Grilo","year":"2024","journal-title":"Mol. Syst. Biol."},{"issue":"10","key":"2026090306314739600_cit7","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/s42255-023-00897-6","article-title":"Efficacy\nand safety of a synthetic\nbiotic for treatment of phenylketonuria: a phase 2 clinical trial","volume":"5","author":"Vockley","year":"2023","journal-title":"Nat. Metab."},{"issue":"11","key":"2026090306314739600_cit8","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining\nremission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"key":"2026090306314739600_cit9","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1000873","article-title":"Microbiome engineering:\nengineered live biotherapeutic products for treating human disease","volume":"10","author":"Rutter","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"2026090306314739600_cit10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41591-025-04076-w","article-title":"The impact\nof an oral purified microbiome therapeutic\non the gastrointestinal microbiome","volume":"32","author":"Bryant","year":"2026","journal-title":"Nat. Med."},{"issue":"3","key":"2026090306314739600_cit11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41578-024-00766-y","article-title":"Delivering living medicines with\nbiomaterials","volume":"10","author":"Harimoto","year":"2025","journal-title":"Nat. Rev. Mater."},{"issue":"19","key":"2026090306314739600_cit12","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1039\/D3CS00369H","article-title":"Surface-modified\nbacteria: synthesis, functionalization and biomedical\napplications","volume":"52","author":"Lin","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"2026090306314739600_cit13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acs.accounts.3c00798","article-title":"Dopamine polymerization-mediated\nsurface functionalization toward\nadvanced bacterial therapeutics","volume":"57","author":"Wang","year":"2024","journal-title":"Acc. Chem.\nRes."},{"issue":"13","key":"2026090306314739600_cit14","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acs.accounts.5c00271","article-title":"Regulating bacteria-host interactions\nfor disease intervention by\ncovalent conjugation of bacterial surface","volume":"58","author":"Chen","year":"2025","journal-title":"Acc.\nChem. Res."},{"issue":"13","key":"2026090306314739600_cit15","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007379","article-title":"Polymerization-mediated\nmultifunctionalization\nof living cells for enhanced cell-based therapy","volume":"33","author":"Pan","year":"2021","journal-title":"Adv. Mater."},{"issue":"12","key":"2026090306314739600_cit16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41570-020-00221-w","article-title":"Biosynthesis of inorganic nanomaterials using microbial\ncells and bacteriophages","volume":"4","author":"Choi","year":"2020","journal-title":"Nat. Rev. Chem."},{"issue":"6","key":"2026090306314739600_cit17","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10534-014-9797-5","article-title":"Revised model of calcium and magnesium binding to the\nbacterial cell wall","volume":"27","author":"Thomas","year":"2014","journal-title":"BioMetals"},{"issue":"11","key":"2026090306314739600_cit18","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41596-024-01019-6","article-title":"Surface nanocoating\nof bacteria as a versatile platform to develop\nliving therapeutics","volume":"19","author":"Cao","year":"2024","journal-title":"Nat. Protoc."},{"issue":"3502","key":"2026090306314739600_cit19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1126\/science.135.3502.439","article-title":"Mineralization\nof bacteria","volume":"135","author":"Rizzo","year":"1962","journal-title":"Science"},{"issue":"12","key":"2026090306314739600_cit20","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.3390\/ijms26125716","article-title":"Bacteria under metal stress-molecular\nmechanisms of metal tolerance","volume":"26","author":"Olen\u0301ska","year":"2025","journal-title":"Int. J. Mol.\nSci."},{"issue":"1","key":"2026090306314739600_cit21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12951-025-03141-3","article-title":"Navigating a challenging\npath: precision disease treatment with tailored oral nano-armor-probiotics","volume":"23","author":"Chen","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"32","key":"2026090306314739600_cit22","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310174","article-title":"Intestinal delivery\nof probiotics: materials, strategies, and applications","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"25","key":"2026090306314739600_cit23","doi-asserted-by":"publisher","first-page":"10388","DOI":"10.1021\/acs.jpcc.4c02074","article-title":"Vaterite dissolution: mechanism and\nkinetics","volume":"128","author":"Milner","year":"2024","journal-title":"J. Phys. Chem. C"},{"issue":"1","key":"2026090306314739600_cit24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit:\na technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin. Drug Delivery"},{"issue":"7","key":"2026090306314739600_cit25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/acscentsci.3c00227","article-title":"Calcium tungstate microgel enhances the delivery and\ncolonization of probiotics during colitis via intestinal ecological\nniche occupancy","volume":"9","author":"Yang","year":"2023","journal-title":"ACS Cent. Sci."},{"issue":"18","key":"2026090306314739600_cit26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308728","article-title":"Responsively degradable\nnanoarmor-assisted super resistance and stable\ncolonization of probiotics for enhanced inflammation-targeted delivery","volume":"36","author":"Zhu","year":"2024","journal-title":"Adv. Mater."},{"issue":"31","key":"2026090306314739600_cit27","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202402240","article-title":"Stimuli-responsive NO delivery platforms for bacterial infection\ntreatment","volume":"13","author":"Hu","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"8","key":"2026090306314739600_cit28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41579-018-0036-x","article-title":"Interactions\nof commensal and pathogenic\nmicroorganisms with the intestinal mucosal barrier","volume":"16","author":"Martens","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"2026090306314739600_cit29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/polym14040687","article-title":"Applications of\nthe ROS-responsive\nthioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers"},{"issue":"8","key":"2026090306314739600_cit30","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/acsnano.2c05558","article-title":"Design of diselenide-bridged\nhyaluronic acid nano-antioxidant for efficient ROS scavenging to relieve\ncolitis","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"issue":"1","key":"2026090306314739600_cit31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2026.2612836","article-title":"The human gut microbiome\nin enteric infections: from association to translation","volume":"18","author":"Yin","year":"2026","journal-title":"Gut Microbes"},{"key":"2026090306314739600_cit32","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.121472","article-title":"The single-cell\nmodification strategies for probiotics delivery in inflammatory bowel\ndisease: a review","volume":"324","author":"Han","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"2026090306314739600_cit33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.actbio.2025.07.058","article-title":"Endogenous\nstimuli-activatable photothermal therapy for bacterial infections","volume":"204","author":"Liu","year":"2025","journal-title":"Acta Biomater."},{"issue":"33","key":"2026090306314739600_cit34","doi-asserted-by":"publisher","first-page":"36967","DOI":"10.1021\/acsami.0c11959","article-title":"Encapsulation\nof Lactobacillus rhamnosus in hyaluronic acid-based hydrogel for pathogen-targeted\ndelivery to ameliorate enteritis","volume":"12","author":"Xiao","year":"2020","journal-title":"ACS Appl.\nMater. Interfaces"},{"issue":"8","key":"2026090306314739600_cit35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","article-title":"Microbiota in inflammatory bowel\ndisease: mechanisms of disease and therapeutic opportunities","volume":"23","author":"Iliev","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"2026090306314739600_cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2026.114714","article-title":"Slug-mucus-inspired single-cell coating enhances the\ntreatment of\ninflammatory bowel disease by improving probiotic colonization efficiency","volume":"392","author":"Yang","year":"2026","journal-title":"J. Controlled Release"},{"key":"2026090306314739600_cit37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2026.123984","article-title":"Fucoidan-based hydrogel with ultrafast\nself-healing properties for enhanced probiotic delivery to alleviate\ncolitis and microbiota dysbiosis in mice","volume":"329","author":"Liu","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"2026090306314739600_cit38","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2542384","article-title":"Multi-omics integration\nreveals functional signatures of gut microbiome\nin atherosclerosis","volume":"17","author":"Shi","year":"2025","journal-title":"Gut Microbes"},{"issue":"8079","key":"2026090306314739600_cit39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-025-09263-w","article-title":"Imidazole propionate is a driver and therapeutic target\nin atherosclerosis","volume":"645","author":"Mastrangelo","year":"2025","journal-title":"Nature"},{"issue":"6","key":"2026090306314739600_cit40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.123.063914","article-title":"Streptococcus species abundance in the gut is linked\nto subclinical coronary atherosclerosis\nin 8973 participants from the SCAPIS cohort","volume":"148","author":"Sayols-Baixeras","year":"2023","journal-title":"Circulation"}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.6c00272","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/17\/2761\/66467832\/acs.accounts.6c00272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/17\/2761\/66467832\/acs.accounts.6c00272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:31:55Z","timestamp":1788431515000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/59\/17\/2761\/5250881\/Stimuli-Responsive-Nanocoatings-Enable-Controlled"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":40,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,8,10]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.6c00272","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}